Details
Stereochemistry | ACHIRAL |
Molecular Formula | C31H35F6N4O5P |
Molecular Weight | 688.5976 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C2=CN=C(C=C2C3=C(C)C=CC=C3)N4CC[N+](C)(COP(O)([O-])=O)CC4
InChI
InChIKey=HZIYEEMJNBKMJH-UHFFFAOYSA-N
InChI=1S/C31H35F6N4O5P/c1-20-8-6-7-9-24(20)25-17-27(40-10-12-41(5,13-11-40)19-46-47(43,44)45)38-18-26(25)39(4)28(42)29(2,3)21-14-22(30(32,33)34)16-23(15-21)31(35,36)37/h6-9,14-18H,10-13,19H2,1-5H3,(H-,43,44,45)
Molecular Formula | C31H35F6N4O5P |
Molecular Weight | 688.5976 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:15:36 UTC 2023
by
admin
on
Sat Dec 16 11:15:36 UTC 2023
|
Record UNII |
T672P80L2S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5283
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
C170011
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
1703748-89-3
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
10146
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
DTXSID601027641
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
DB14019
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
2044417
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
100000176234
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
71544786
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
T672P80L2S
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
T672P80L2S
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY | |||
|
1431216-59-9
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
ALTERNATIVE | |||
|
EF-24
Created by
admin on Sat Dec 16 11:15:36 UTC 2023 , Edited by admin on Sat Dec 16 11:15:36 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
INJECTION ADMINISTRATION |
|
||
Tmax | PHARMACOKINETIC |
|
INJECTION ADMINISTRATION |
|
||